Eli Lilly’s weight loss pill succeeds in first late-stage trial on diabetes patients

Eli Lilly’s weight loss pill succeeds in first late-stage trial on diabetes patients

Eli Lilly on Thursday said its daily obesity pill met the company’s goals in the first of several late-stage trials, helping patients with Type 2 diabetes lower their blood sugar and body weight and showing safety comparable with popular injections on the market.  The trial results are among the pharmaceutical industry’s most closely watched studies … Read more

Eli Lilly will soon release key data on its weight loss pill. Here’s why it could be a game-changer

Eli Lilly will soon release key data on its weight loss pill. Here’s why it could be a game-changer

A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Patients, doctors and investors will soon learn a lot more about a new, more convenient treatment that could shake up the booming weight loss drug market. Eli Lilly plans to … Read more

AbbVie is the newest potential weight loss drug player

AbbVie is the newest potential weight loss drug player

A sign stands outside an Abbvie facility in Cambridge, Massachusetts. Brian Snyder | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. The booming weight loss drug market has gained a new potential competitor.  AbbVie … Read more